Michael Darron Robbins

Title: Michael Darron Robbins: Innovator in Cancer Treatment

Introduction

Michael Darron Robbins is a notable inventor based in Hillsborough, NJ (US). He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 2 patents, Robbins has focused on enhancing therapeutic efficacy in immunotherapy.

Latest Patents

Robbins' latest patents include groundbreaking inventions aimed at treating cancer. One of his patents is titled "Immunotherapeutic dosing regimens comprising pomalidomide and an anti-CS1 antibody for treating cancer." This invention relates to therapeutic dosing regimens and combinations designed to enhance the efficacy of anti-CS1 antibodies when used alongside one or more immunotherapeutic agents. Another significant patent is "Combination of anti-KIR and anti-CS1 antibodies to treat multiple myeloma." This patent provides methods for the clinical treatment of multiple myeloma using an anti-KIR antibody in combination with an anti-CS1 antibody.

Career Highlights

Throughout his career, Robbins has worked with prominent companies in the pharmaceutical industry. He has been associated with Bristol-Myers Squibb Company and Innate Pharma, where he has contributed to the development of innovative cancer therapies.

Collaborations

Robbins has collaborated with esteemed colleagues in his field, including Pascale Andre and Mathieu Blery. Their combined expertise has further advanced the research and development of effective cancer treatments.

Conclusion

Michael Darron Robbins is a distinguished inventor whose work in cancer treatment has the potential to significantly impact patient care. His innovative patents and collaborations highlight his commitment to advancing medical science.